Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire

Active, not recruitingOBSERVATIONAL

Enrollment

1,568

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions

MalariaAnemia

Interventions

DRUG

Sulfadoxine pyrimethamine

Sulfadoxine-pyrimethamine paediatric formulation (250mg/12.5mg) dispersable tablets (Macleods Pharmaceuticals Ltd)

Trial Locations (1)

Multiple, Séguéla

All Listed Sponsors

collaborator

Institut National de Santé Publique de Côte d'Ivoire

UNKNOWN

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT05856357 - Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire | Biotech Hunter | Biotech Hunter